The Company’s long-term vision is to build an integrated operating platform across wellness, entertainment, media, and technology that generates diversified revenue and durable brand equity.
Limitless X Holdings is a holding company with operating subsidiaries. Strategy, capital allocation, governance, and brand alignment are managed at the parent level.
The subsidiaries are designed to share infrastructure, brand assets, data, and distribution channels to improve efficiency and reduce reliance on third-party marketing and intermediaries.
No. Management’s strategy is to reduce dependence on any single product, customer, or event by diversifying revenue streams across multiple verticals.
Revenue may be generated from direct-to-consumer product sales, live sports and entertainment events, sponsorships, media and content, licensing, and technology-enabled engagement.
Some revenues, such as consumer product sales and repeat customer purchases, are intended to be recurring. Other revenues, such as events and media, may be episodic.
The Company may work with athletes and talent, but its strategy emphasizes owned distribution and equity-aligned relationships rather than short-term paid endorsements.
Bodycor Inc. is a technology subsidiary focused on developing AI-driven tools intended to enhance personalization, engagement, and operational efficiency across the ecosystem.
No. Bodycor is not a diagnostics or medical company and does not provide medical advice or diagnoses.
The Bodycor technology is not currently under development. As such, there is no assurance as to if or when development may begin, or whether it will result in a commercial product.
Reg A+ allows the Company to raise growth capital while expanding its shareholder base and maintaining public-company transparency.
Proceeds are intended to support operations, product expansion, technology development, media and sports initiatives, and general corporate purposes.
Investment limits, minimums, and eligibility requirements are disclosed in the offering circular.
Yes. Management retains discretion to allocate proceeds based on business needs and market conditions.
The Company’s common stock trades on the OTCQX market under the ticker symbol LIMX.
There is no assurance that an active or liquid trading market will continue to exist.
Yes. The market price of the Company’s securities may be volatile and may decline regardless of Company performance.
Any future uplisting is subject to regulatory approval, market conditions, and Company performance. No assurance can be given.
Future financings, equity compensation, or strategic transactions may result in dilution to existing shareholders.
Management seeks to balance growth opportunities with capital discipline, but dilution may be necessary to fund operations and expansion.
The Company does not currently anticipate paying dividends. Any future dividends are subject to board approval and financial performance.
Potential investor returns may come from long-term appreciation in the value of the Company’s securities, subject to market conditions and execution.
Yes. An investment in the Company involves significant risk, including the risk of losing some or all of your investment.
This offering may be suitable for investors who understand speculative investments and can bear long-term risk and limited liquidity.
Comprehensive risk disclosures are included in the Company’s Form 1-A offering circular.
Yes. The Company is subject to ongoing reporting and disclosure obligations.
Financial statements, offering materials, and filings are available on ir.limitlessx.com and through applicable regulatory databases.
The Company provides updates through press releases, SEC filings, and its investor relations website.
Management and affiliates may own shares, aligning leadership with shareholders.
Investor inquiries can be directed through the contact information listed on ir.limitlessx.com.